Hostname: page-component-cd9895bd7-hc48f Total loading time: 0 Render date: 2024-12-31T16:26:05.941Z Has data issue: false hasContentIssue false
  • English
  • Français

Chlorhexidine Bathing in a Tertiary Care Neonatal Intensive Care Unit: Impact on Central Line–Associated Bloodstream Infections

Part of: WILLIAM JARVIS AWARD RECIPIENTS

Published online by Cambridge University Press:  10 May 2016

Caroline Quach ,
Aaron M. Milstone ,
Chantal Perpête ,
Mario Bonenfant ,
Dorothy L. Moore  and
Therese Perreault
Caroline Quach*
Affiliation:
Division of Infection Control, Department of Pediatrics, Montreal Children's Hospital, McGill University Health Centre, Montreal, Quebec, Canada Division of Infectious Diseases, Department of Pediatrics, McGill University, Montreal, Quebec, Canada Department of Epidemiology, Biostatistics, and Occupational Health, McGill University, Montreal, Quebec, Canada
Aaron M. Milstone
Affiliation:
Division of Infectious Diseases, Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, Maryland Department of Hospital Epidemiology and Infection Control, Johns Hopkins Hospital, Baltimore, Maryland
Chantal Perpête
Affiliation:
Division of Infection Control, Department of Pediatrics, Montreal Children's Hospital, McGill University Health Centre, Montreal, Quebec, Canada
Mario Bonenfant
Affiliation:
Division of Neonatology, Department of Pediatrics, McGill University, Montreal, Quebec, Canada
Dorothy L. Moore
Affiliation:
Division of Infection Control, Department of Pediatrics, Montreal Children's Hospital, McGill University Health Centre, Montreal, Quebec, Canada Division of Infectious Diseases, Department of Pediatrics, McGill University, Montreal, Quebec, Canada
Therese Perreault
Affiliation:
Division of Neonatology, Department of Pediatrics, McGill University, Montreal, Quebec, Canada
*
Montreal Children's Hospital, C1242-2300 Tupper Street, Montreal, Quebec H3H 1P3, Canada ([email protected])
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Background.

Despite implementation of recommended best practices, our central line-associated bloodstream infection (CLABSI) rates remained high. Our objective was to describe the impact of chlorhexidine gluconate (CHG) bathing on CLABSI rates in neonates.

Methods.

Infants with a central venous catheter (CVC) admitted to the neonatal intensive care unit from April 2009 to March 2013 were included. Neonates with a birth weight of 1,000 g or less, aged less than 28 days, and those with a birth weight greater than 1,000 g were bathed with mild soap until March 31, 2012 (baseline), and with a 2% CHG-impregnated cloth starting on April 1, 2012 (intervention). Infants with a birth weight of 1,000 g or less, aged 28 days or more, were bathed with mild soap during the entire period. Neonatal intensive care unit nurses reported adverse events. Adjusted incidence rate ratios (aIRRs), using Poisson regression, were calculated to compare CLABSIs/1,000 CVC-days during the baseline and intervention periods.

Results.

Overall, 790 neonates with CVCs were included in the study. CLABSI rates decreased during the intervention period for CHG-bathed neonates (6.00 vs 1.92/1,000 CVC-days; aIRR, 0.33 [95% confidence interval (CI), 0.15-0.73]) but remained unchanged for neonates with a birth rate of 1,000 g or less and aged less than 28 days who were not eligible for CHG bathing (8.57 vs 8.62/1,000 CVC-days; aIRR, 0.86 [95% CI, 0.17-4.44]). Overall, 195 infants with a birth weight greater than 1,000 g and 24 infants with a birth weight of 1,000 g or less, aged 28 days or more, were bathed with CHG. There was no reported adverse event.

Conclusions.

We observed a decrease in CLABSI rates in CHG-bathed neonates in the absence of observed adverse events. CHG bathing should be considered if CLABSI rates remain high, despite the implementation of other recommended measures.

Type
Original Article
Information
Infection Control & Hospital Epidemiology , Volume 35 , Issue 2 , February 2014 , pp. 158 - 163
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2014

References

1. Brodie, SB, Sands, KE, Gray, JE, et al. Occurrence of nosocomial bloodstream infections in six neonatal intensive care units. Pediatr Infect Dis J 2000;19(1):56–65.CrossRefGoogle ScholarPubMed
2. Schulman, J, Stricof, R, Stevens, TP, et al. Statewide NI CU central-line-associated bloodstream infection rates decline after bundles and checklists. Pediatrics 2011;127(3):436–444.Google Scholar
3. Goldmann, DA, Freeman, J, Durbin, WA Jr. Nosocomial infection and death in a neonatal intensive care unit. J Infect Dis 1983; 147(4):635–641.Google Scholar
4. Shah, DK, Doyle, LW, Anderson, PJ, et al. Adverse neurodevelopment in preterm infants with postnatal sepsis or necrotizing enterocolitis is mediated by white matter abnormalities on magnetic resonance imaging at term. J Pediatr 2008;153(2):170–175.e1.CrossRefGoogle ScholarPubMed
5. Schlapbach, LJ, Aebischer, M, Adams, M, et al. Impact of sepsis on neurodevelopmental outcome in a Swiss National Cohort of extremely prernature infants. Pediatrics 2011;128(2):e348–e357.CrossRefGoogle Scholar
6. O'Grady, NP, Alexander, M, Burns, LA, et al. Guidelines for the prevention of intravascular catheter-related infections. Clin Infect Dis 2011;52(9):e162–e193.CrossRefGoogle ScholarPubMed
7. Chapman, AK, Aucott, SW, Milstone, AM. Safety of chlorhexidine gluconate used for skin antisepsis in the preterm infant. J Perinatal 2012;32(1):4–9.CrossRefGoogle ScholarPubMed
8. Milstone, AM, Passaretti, CL, Perl, TM. chlorhexidine: expanding the armamentarium for infection control and prevention. Clin Infect Dis 2008;46(2):274–281.Google ScholarPubMed
9. Karki, S, Cheng, AC. Impact of non-rinse skin cleansing with chlorhexidine gluconate on prevention of healthcare-associated infections and colonization with multi-resistant organisms: a systematic review. J Hosp Infect 2012;82(2):71–84.CrossRefGoogle ScholarPubMed
10. Exline, MC, Ali, NA, Zikri, N, et al. Beyond the bundle: journey of a tertiary care medical intensive care unit to zero central line-associated bloodstream infections. Crit Care 2013;17(2):R41.CrossRefGoogle ScholarPubMed
11. Climo, MW, Yokoe, DS, Warren, DK, et al. Effect of daily chlorhexidine bathing on hospital-acquired infection. N Engl J Med 2013;368(6):533–542.CrossRefGoogle ScholarPubMed
12. Montecalvo, MA, McKenna, D, Yarrish, R, et al. chlorhexidine bathing to reduce central venous catheter-associated bloodstream infection: impact and sustainability. Am J Med 2012; 125(5):505–511.Google ScholarPubMed
13. Rupp, ME, Cavalieri, RJ, Lyden, E, et al. Effect of hospital-wide chlorhexidine patient bathing on healthcare-associated infections. Infect Control Hosp Epidemiol 2012;33(11):1094–1100.CrossRefGoogle ScholarPubMed
14. Milstone, AM, Elward, A, Song, X, et al. Daily chlorhexidine bathing to reduce bacteraemia in critically ill children: a multicentre, cluster-randomised, crossover trial. Lancet 2013;381(9872): 1099–1106.CrossRefGoogle ScholarPubMed
15. Tamma, PD, Aucott, SW, Milstone, AM. Chlorhexidine use in the neonatal intensive care unit: results from a national survey. Infect Control Hosp Epidemiol 2010;31(8):846–849.CrossRefGoogle ScholarPubMed
16. Horan, TC, Andrus, M, Dudeck, MA. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control 2008;36(5):309–332.CrossRefGoogle ScholarPubMed
17. Horan, TC, Arnold, KE, Rebmann, CA, Fridkin, SK. Network approach for prevention of healthcare-associated infections. Infect Control Hosp Epidemiol 2011;32(11):1143–1144.CrossRefGoogle ScholarPubMed
18. Horan, TC, Emori, TG. Definitions of key terms used in the NNIS System. Am J Infect Control 1997;25(2):112–116.CrossRefGoogle ScholarPubMed
19. Horan, TC, Lee, TB. Surveillance: into the next millennium. Am J Infect Control 1997;25(2):73–76.Google ScholarPubMed
20. National Healthcare Safety Network. Device-Associated Module CLABSI. Atlanta: Centers for Disease Control and Prevention, 2013. http://www.cdc.gov/nhsn/PDFs/pscManual/4PSC_CLABScurrent.pdf. Accessed July 29, 2013.Google Scholar
21. Centers for Disease Control and Prevention (CDC). Device-Associated (DA) Module. Atlanta: CDC, 2009. http://www.cdc.gov/nhsn/PDFs/pscManual/4PSC_CLABScurrent.pdf. Accessed December 16, 2013.Google Scholar
22. National Nosocomial Infections Surveillance System. National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control 2004;32(8):470–485.CrossRefGoogle Scholar
23. Shuman, RM, Leech, RW, Alvord, EC Jr. Neurotoxicity of hexa-chlorophene in humans. II. A clinicopathological study of 46 premature infants. Arch Neurol 1975;32(5):320–325.CrossRefGoogle Scholar
24. Kimbrough, RD. Review of recent evidence of toxic effects of hexachlorophene. Pediatrics 1973;51(2):391–394.CrossRefGoogle ScholarPubMed
25. Tyrala, EE, Hillman, LS, Hillman, RE, Dodson, WE. Clinical pharmacology of hexachlorophene in newborn infants. J Pediatr 1977;91(3):481–486.CrossRefGoogle ScholarPubMed
26. Klieger, SB, Potter-Bynoe, G, Quach, C, Sandora, TJ, Coffin, SE. Beyond the bundle: a survey of central line-associated bloodstream infection prevention practices used in US and Canadian pediatric hospitals. Infect Control Hosp Epidemiol 2013;34:1208–1210.CrossRefGoogle Scholar
27. Cowen, J, Ellis, SH, McAinsh, J. Absorption of chlorhexidine from the intact skin of newborn infants. Arch Dis Child 1979;54(5): 379–383.CrossRefGoogle ScholarPubMed
28. Garland, JS, Alex, CP, Uhing, MR, Peterside, IE, Rentz, A, Harris, MC. Pilot trial to compare tolerance of chlorhexidine gluconate to povidone-iodine antisepsis for central venous catheter placement in neonates. J Perinatal 2009;29(12):808–813.CrossRefGoogle ScholarPubMed
29. Chapman, AK, Aucott, SW, Gilmore, MM, Advani, S, Clarke, W, Milstone, AM. Absorption and tolerability of aqueous chlorhexidine gluconate used for skin antisepsis prior to catheter insertion in preterm neonates. J Perinatol 2013;33:768–771.CrossRefGoogle ScholarPubMed
30. Lee, A, Harlan, R, Breaud, AR, et al. Blood concentrations of chlorhexidine in hospitalized children undergoing daily chlorhexidine bathing. Infect Control Hosp Epidemiol 2011;32(4):395–397.CrossRefGoogle ScholarPubMed
31. Gongwer, LE, Hubben, K, Lenkiewicz, RS, Hart, ER, Cockrell, BY. The effects of daily bathing of neonatal rhesus monkeys with an antimicrobial skin cleanser containing chlorhexidine gluconate. Toxicol Appl Pharmacol 1980;52(2):255–261.CrossRefGoogle ScholarPubMed
32. Adams-Chapman, I, Stoll, BJ. Neonatal infection and long-term neurodevelopmental outcome in the preterm infant. Curr Opin Infect Dis 2006;19(3):290–297.CrossRefGoogle ScholarPubMed
33. Fritz, SA, Hogan, PG, Camins, BC, et al. Mupirocin and shlorhexidine resistance in Staphylococcus aureus in patients with community-onset skin and soft tissue infections. Antimicrob Agents Chemother 2013;57(1):559–568.CrossRefGoogle ScholarPubMed
34. Sangal, V, Girvan, EK, Jadhav, S, et al. Impacts of a long-term programme of active surveillance and Chlorhexidine baths on the clinical and molecular epidemiology of meticillin-resistant Staphylococcus aureus (MRSA) in an intensive care unit in Scotland. Int J Antimicrob Agents 2012;40(4):323–331.Google Scholar
35. Soma, VL, Qin, X, Zhou, C, Adler, A, Berry, JE, Zerr, DM. The effects of daily chlorhexidine bathing on cutaneous bacterial isolates: a pilot study. Infect Drug Resist 2012;5:75–78.CrossRefGoogle ScholarPubMed
36. Popovich, KJ, Lyles, R, Hayes, R, et al. Relationship between chlorhexidine gluconate skin concentration and microbial density on the skin of critically ill patients bathed daily with chlorhexidine gluconate. Infect Control Hosp Epidemiol 2012;33(9):889–896.CrossRefGoogle ScholarPubMed